Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette, DS O'Callaghan, C Jardim… - Journal of Receptor …, 2010 - Taylor & Francis
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …
被引用次数：10 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette - Journal of Receptor, Ligand and Channel …, 2010 - pdfs.semanticscholar.org
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …
[PDF] academia.edu

[PDF][PDF] Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette - Journal of Receptor, Ligand and Channel Research, 2010 - academia.edu
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …

Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette, DS O'Callaghan, C Jardim… - Journal of Receptor …, 2010 - dovepress.com
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …
[PDF] archive.org

[PDF][PDF] Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette - Journal of Receptor, Ligand and Channel Research, 2010 - scholar.archive.org
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …
[PDF] researchgate.net

[PDF][PDF] Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette - Journal of Receptor, Ligand and Channel Research, 2010 - researchgate.net
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …

Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette, DS O'Callaghan, C Jardim… - Journal of Receptor …, 2010 - search.proquest.com
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …
[PDF] psu.edu

[PDF][PDF] Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette - Journal of Receptor, Ligand and Channel Research, 2010 - Citeseer
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …
[PDF] academia.edu

[PDF][PDF] Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette - Journal of Receptor, Ligand and Channel Research, 2010 - academia.edu
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …

Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension

S Hoette, DS O'Callaghan, C Jardim… - Journal of Receptor …, 2010 - dovepress.com
Pulmonary hypertension is characterized by an increase in mean pulmonary arterial
pressure and right ventricular overload. Endothelin-1 (ET-1) is a potent vasoconstrictor with …